On January 29, 2019, the Senate and House held separate hearings on prescription drug prices. The Senate Finance Committee’s hearing, Drug Pricing in America: A Prescription for Change, Part 1, explored the rising cost of prescription drugs and … [Read more...] about Congressional Hearings Explore Rising Prescription Drug Costs
Medicare Part D / Prescription Drugs
Don’t Fall for the Distraction: The President’s Prescription Drug Proposal is Much Ado About Much Too Little
With the mid-term elections just days away, the President unveiled a minimal drug proposal in yet another effort to suggest minor changes at a politically opportune time. This is a distraction from the fact that the Administration is … [Read more...] about Don’t Fall for the Distraction: The President’s Prescription Drug Proposal is Much Ado About Much Too Little
Special Report: Recent Changes in Law, Regulations and Guidance Relating to Medicare Advantage and the Prescription Drug Benefit Program
September 2018 Numerous changes were made to Medicare law, regulations and guidance during the first half of 2018.The changes are particularly noteworthy regarding Part C, governing private Medicare plans, known as Medicare Advantage (MA), and … [Read more...] about Special Report: Recent Changes in Law, Regulations and Guidance Relating to Medicare Advantage and the Prescription Drug Benefit Program
Dual Eligibles and Access to Part D Drugs: Pretty Good News from the OIG
The Office of the Inspector General for the Department of Health and Human Services released a report recently regarding Part D coverage of prescription drugs used by people dually eligible for Medicare and Medicaid. The June report, Part D Plans … [Read more...] about Dual Eligibles and Access to Part D Drugs: Pretty Good News from the OIG
The Right Way to Lower Medicare Prescription Drug Costs
Robert Pear wrote last week in the New York Times (“Trump Plan to Lower Drug Prices Could Increase Costs for Some Patients”) that the President’s plan to “inject more competition into the market” and switch coverage of … [Read more...] about The Right Way to Lower Medicare Prescription Drug Costs
The Center for Medicare Advocacy and Florida Health Justice Project Sue to Obtain “Off-label” Part D Prescription Drug Coverage for Beneficiary
On April 6, 2018 the Center for Medicare Advocacy and Florida Health Justice Project filed a lawsuit in U.S. District Court for the Southern District of Florida on behalf of a 49-year-old beneficiary seeking Medicare coverage for his … [Read more...] about The Center for Medicare Advocacy and Florida Health Justice Project Sue to Obtain “Off-label” Part D Prescription Drug Coverage for Beneficiary
Center for Medicare Advocacy and Florida Health Justice Project Sue to Obtain “Off-label” Part D Prescription Drug Coverage for Beneficiary
April 16, 2018 For Immediate Release Contact: Center for Medicare Advocacy – Kata Kertesz: KKertesz@MedicareAdvocacy.org, 202-293-5760 Florida Health Justice Project – Miriam Harmatz: Harmatz@FloridaHealthJustice.org, … [Read more...] about Center for Medicare Advocacy and Florida Health Justice Project Sue to Obtain “Off-label” Part D Prescription Drug Coverage for Beneficiary
Center for Medicare Advocacy Submits Comments to CMS’ Draft 2019 Call Letter for Medicare Advantage and Part D
On February 1, 2018, the Centers for Medicare & Medicaid Services (CMS) issued its draft 2019 Call Letter, an annual set of proposed rules, guidelines and clarifications for Part C Medicare Advantage (MA) and Part D plans that wish to participate … [Read more...] about Center for Medicare Advocacy Submits Comments to CMS’ Draft 2019 Call Letter for Medicare Advantage and Part D
Bill to Control Medicare Prescription Drug Costs Introduced
Representative Sandy Levin recently introduced the Protecting Medicare from Excessive Price Increases Act, which would require prescription drug manufacturers to pay a rebate when the price of their Part B drug increases faster than inflation. … [Read more...] about Bill to Control Medicare Prescription Drug Costs Introduced
Center Urges CMS to Preserve and Strengthen Consumer Protections in Medicare Advantage and Part D
As noted in a previous Alert, the Center for Medicare & Medicaid Services (CMS) recently finalized their 2018 Call Letter. In the same document, CMS issued a Request for Information regarding ideas for “regulatory, sub-regulatory, … [Read more...] about Center Urges CMS to Preserve and Strengthen Consumer Protections in Medicare Advantage and Part D